Literature DB >> 13295487

The preparation and function of the hypertensin-converting enzyme.

L T SKEGGS, J R KAHN, N P SHUMWAY.   

Abstract

It has been shown by use of isolated, perfused rat kidneys that hypertensin II is a potent vasoconstrictor substance while hypertensin I is not. Hence it would appear that in intact animals the pressor activity of hypertensin I results from its rapid conversion to hypertensin II. An enzyme which effects this conversion has been procured from horse plasma in a semipurified form by means of ammonium sulfate fractionation and isoelectric precipitation. A method is described for estimating the activity of the enzyme. An example of the use of the preparation in converting purified hypertensin I to hypertensin II has been described.

Entities:  

Keywords:  ANGIOTONIN; ENZYMES

Mesh:

Substances:

Year:  1956        PMID: 13295487      PMCID: PMC2136590          DOI: 10.1084/jem.103.3.295

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  6 in total

1.  A modified ninhydrin reagent for the photometric determination of amino acids and related compounds.

Authors:  S MOORE; W H STEIN
Journal:  J Biol Chem       Date:  1954-12       Impact factor: 5.157

2.  A method of assaying small amounts of hypertensin.

Authors:  L T SKEGGS; J R KAHN; W H MARSH
Journal:  Lab Invest       Date:  1953 Mar-Apr       Impact factor: 5.662

3.  Artificial kidney; construction and operation of an improved continuous dialyzer.

Authors:  L T SKEGGS; J R LEONARDS; C R HEISLER
Journal:  Proc Soc Exp Biol Med       Date:  1949-12

4.  The purification of hypertensin I.

Authors:  L T SKEGGS; W H MARSH; J R KAHN; N P SHUMWAY
Journal:  J Exp Med       Date:  1954-10-01       Impact factor: 14.307

5.  The existence of two forms of hypertensin.

Authors:  L T SKEGGS; W H MARSH; J R KAHN; N P SHUMWAY
Journal:  J Exp Med       Date:  1954-03       Impact factor: 14.307

6.  Amino acid composition and electrophoretic properties of hypertensin I.

Authors:  L T SKEGGS; W H MARSH; J R KAHN; N P SHUMWAY
Journal:  J Exp Med       Date:  1955-10-01       Impact factor: 14.307

  6 in total
  134 in total

Review 1.  Historical perspective of the renin-angiotensin system.

Authors:  John E Hall
Journal:  Mol Biotechnol       Date:  2003-05       Impact factor: 2.695

2.  [Studies on serum angiotensinase. II. Clinical results in hypertension and liver diseases].

Authors:  D KLAUS; H KAFFARNIK; H PFEIL
Journal:  Klin Wochenschr       Date:  1963-04-15

3.  [Research on the production of angiotensin II (hypertensin II)].

Authors:  M TAUBERT; H H WAGNER
Journal:  Klin Wochenschr       Date:  1962-01-01

4.  [Angiotensin].

Authors:  F GROSS
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1963

5.  [Circulatory studies with synthetic hypertensin II].

Authors:  E F GERSMEYER; H SPITZBARTH; H WEYLAND
Journal:  Klin Wochenschr       Date:  1958-11-15

6.  [Not Available].

Authors:  R MEIER; F GROSS; J TRIPOD; H TURRIAN
Journal:  Experientia       Date:  1957-09-15

7.  Pain-producing substance in human inflammatory exudates and plasma.

Authors:  D ARMSTRONG; J B JEPSON; C A KEELE; J W STEWART
Journal:  J Physiol       Date:  1957-02-15       Impact factor: 5.182

8.  [Renin and hypertension, physiological or pathological agents?].

Authors:  F GROSS
Journal:  Klin Wochenschr       Date:  1958-08-01

9.  [Effect of synthetic hypertensin II on PAH- and inulin clearance, on renal hemodynamics and on diuresis in man].

Authors:  H D BOCK; H J KRECKE
Journal:  Klin Wochenschr       Date:  1958-01-15

10.  Novel activity of angiotensin-converting enzyme. Hydrolysis of cholecystokinin and gastrin analogues with release of the amidated C-terminal dipeptide.

Authors:  P Dubreuil; P Fulcrand; M Rodriguez; H Fulcrand; J Laur; J Martinez
Journal:  Biochem J       Date:  1989-08-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.